• 생물정신의학
• /
• 제13권4호
• /
• pp.234-243
• /
• 2006

정신병적 우울증의 심한 정도와 나쁜 예후, 그리고 현재까지의 연구 실적을 고려했을 때, 임상의사들은 정신병적 증상을 동반한 우울증과 정신병적 증상을 동반하지 않는 우울증을 구분하여 치료계획을 수립하는 것이 바람직하다. 저자들은 체계적인 검색을 통해 광범위하게 조사를 하였으나, 정신병적 우울증 환자의 약물치료에 대한 근거는 아직 부족한 것으로 생각한다. 소수의 연구 결과들이지만 현재까지 발표된 근거에 의하면, 항우울제와 항정신병약물의 병합치료와 전기충격요법이 그 효과에 대한 근거 수준이 가장 높아서 정신병적 우울증 환자를 위한 일차적 치료법으로 생각된다. 그러나 최근에 항우울제 단독치료가 항우울제와 항정신병약물의 병합치료에 비해 효과 면에서 떨어지지 않는다는 분석 결과가 발표되면서 항우울제-항정신병약물 병합치료법과 항우울제를 사용하다가 필요시에 항정신병약물을 추가하는 방법 둘 다 권고된 바 있다. 이는 기존 치료 권고 사항과 대조가 되기 때문에, 향후 이러한 관점에서 기존의 치료 전략들이 어떻게 영향을 받을지 주목된다. 그러나 적어도 정신병적 우울증 환자에게 항정신병약물을 단독으로 사용하는 것은 항우울제와 병합하였을 때 보다 덜 효과적이므로 항정신병약물 단독으로 시작하는 것은 바람직하지 않다는 데에는 연구자들 간에 의견이 일치하고 있다. 항우울제 중에서는 삼환계 항우울제에 대한 근거 수준이 가장 높고 선택적 세로토닌 재흡수 차단제의 경우 현재는 근거가 부족하나 앞으로 유망할 것으로 보인다. 항우울제와 항정신병약물 병합 치료에 반응이 없거나 부작용으로 인해 투여할 수가 없을 경우에는 항우울제의 종류를 바꾸거나 lithium을 강화하는 방법을 고려할 수 있다. 실제 임상에서는 환자 개개인의 위험과 이득을 고려하여 약물을 선택하는 것이 중요하다. 또한 선택된 약물을 충분한 양, 그리고 충분한 기간 동안 시도했는지도 중요하다. 이와 함께 부작용의 출현에 대해 잘 모니터링을 해야 하고, 특히 우울증 자체가 악화되는 것과 구분해야 한다. 결론적으로, 임상의사들은 정신병적 증상을 동반하는 우울증 환자의 치료 전략을 현재까지 수행된 연구 근거의 양과 수준을 감안하여 받아들여야 하고, 아직까지 명백한 결론을 이끌어내기에는 부족하기 때문에 향후 이에 대한 많은 체계적 연구들이 필요할 것이다.

• 동의신경정신과학회지
• /
• 제18권3호
• /
• pp.181-191
• /
• 2007

Jeon-zeong(癲證) is mostly caused by anxiety and melancholy, impairment of heart and the spleen, or stasis of phlegm-Gi and heart confused by phlegm. Its manifestation are characterized by depression, expressionlessness, inclination for quietness, self muttering and hallucinating, caprice in crying and laughing, paraphasia, loss of appetite, unawareness of filth and cleanness, etc. We experienced a 50year-old man who bad brief psycbotic disorder that specified with Marked Stressor and whose condition was improved through oriental medical treatment. We treated the patient with Herbal medications and Giungoroen (至言高論)-wise saying and lofty opinion) and Relaxation therapy. After being treated, the patient showed that symptoms (insomnia, anxiety, depression) was improved considerably. This result suggests that oriental medical treatment has good effect on brief psychotic disorder due to Marked Stressor.

• 성인간호학회지
• /
• 제28권2호
• /
• pp.213-225
• /
• 2016

Purpose: The purpose of this study was to provide basic data about agitation in patients with dementia by surveying the literature. Method: Key words used for search through hand-search and electronic database (CINHAL, Pubmed, Google scholar, Riss, Kiss, DBpia) included 'dementia', 'Alzheimer disease', 'agitation', 'aggression or aggressive behavior', 'problem or disruptive behavior', and 'abnormal behavior.' Seventeen studies met the inclusion criteria for the Meta-analysis and 'R' version 3.2.2 was used to analyze the correlated effect size. Results: Study results showed that variables related to agitation were identified as the demographic (age, gender), dementia-related (cognition, medication uses), physical (Activity of Daily Living [ADL], pain), psychological (depression, psychotic symptom, caregiver burden) and environmental (psychosocial environment) factors. The effect size between the correlated variables and agitation were low to moderate (caregiver burden .36; ADL -.24; psychotic symptom and depression .21; pain .19; cognition -.15; medication uses .12; and psychosocial environment -.12). Conclusion: Based on the findings of this study, strategies to improve patients' depressive and psychotic symptoms and ADL and to reduce caregivers' burden are needed for prevention and management of agitation in patients with dementia.

• 수면정신생리
• /
• 제24권2호
• /
• pp.97-105
• /
• 2017

목 적 : 본 연구의 목적은 불면증과 정신병적 증상이 지속되는 조현병 환자의 수면 장애와 연관된 요인과 수면의 특징을 평가하는 것이다. 방 법 : 지역사회 정신보건 시설에 거주 중이며 불면증과 정신병적 증상이 동반된 조현병 환자들이 참여하였다(n = 63). The Korean version of Insomnia Severity Index (ISIK)와 the Korean Version of Pittsburgh Sleep Quality Index (PSQI-K)와 같은 수면 척도가 평가되었고, ISI-K 점수가 15점 이상인 대상자들이 연구에 참여하였다. 정신병적, 불안, 우울 증상은 각각 Brief Psychotic Rating Scale (BPRS), the Korean Version of Anxiety Sensitivity Index (K-ASI) 그리고 the Korean Version of Beck Depression Inventory-I(K-BDI)로 평가하였다. 사회인구학적 자료와 ISI-K 그리고 PSQI-K 사이의 상관관계를 확인하기 위해 Pearson correlation analysis를 시행하였다. ISI-K와 PSQI-K에 영향을 미치는 각각의 요인을 확인하기 위하여 다중회귀분석으로 분석하였다. 결 과 : ISI-K와 PSQI-K의 평균 점수는 각각 $18.1{\pm}2.6$점과 $12.0{\pm}2.2$점이었다. Pearson correlation analysis 결과에서 발병 연령과 ISI-K사이의 음의 상관관계와 BPRS와 PSQI-K 사이, K-ASI와 모든 수면 척도 사이의 양의 상관관계를 확인하였다. ISI-K와 PSQI-K에 대해 K-ASI와 발병연령, K-ASI와 BPRS를 각각 단계적으로 입력한 모든 다중회귀분석에서 K-ASI만이 유의한 요인으로 남았다. 결 론 : 본 연구는 조현병 환자의 불면 증상이 우울 또는 정신병적 증상과 무관한 반면, 불안 증상과 관련이 있다는 점을 제안한다.

• 정신신체의학
• /
• 제5권1호
• /
• pp.118-122
• /
• 1997

저자들은 13년전 심한 산후 출혈 후에 서서히 진행된 성선, 갑상선, 부신피질호르몬결핍증상과 함께 피해망상, 환청과 이에 따른 행동, 심한 불면증, 정신운동의 지체, 사회적 철퇴 등의 증상을 보인 51세 여자환자의 증례를 경험하였다. 환자는 일견 심한 정신병적 우울증의 양상을 보여 정신과에 입원하였으나 자세한 병력 청취 및 임상양상의 관찰로 내과적 질환에 의한 정신증의 가능성이 고려되었고, 호르몬 검사상 범뇌하수체기능 부전소견과 저혈당증 및 저나트륨혈증 등을 나타내 Sheehan시 증후군의 진단이 가능하였다. 갑상선과 부신피질호르몬의 투여 기타 보존적인 치료에 의해 정신과적증상을 포함한 제반 임상증상이 1주이내에 호전되었다. 저자들은 본 증례의 보고를 통해 정신과 환자에 대한 임상적 접근에서 간과되기 쉬운 내재된 내과적 문제의 감별의 중요성을 다시 한 번 강조하고자 한다.

• 보험의학회지
• /
• 제20권
• /
• pp.70-77
• /
• 2001

Some characteristics of depression in the aged were elucidated. Compared with the previous thoughts, much more attention was given to the biological aspects of depression. However, we have to face up to and solve a variety of enigmas about depression in the aged people. They are:locations and underlying mechanisms in the cerebrum responsible for depression;relationship of senile depression to the presenile one;possible difference(s) between depression with and without psychotic features;possible neurotransmitter differences between senile and presenile depressions. New insights into these areas could bring some lights in the under standing and treatment of depresseion in the aged.

• 생물정신의학
• /
• 제5권2호
• /
• pp.149-154
• /
• 1998

Antipsychotic drugs(APDs) have been effective to alleviate psychotic symptoms of schizophrenia. However, some schizophrenic patients do not respond to APDs. In addition to psychotic symptoms of schizophrenia, negative symptoms, excitement, violence, agitation, depression, and disorganization are frequently noted in patients with schizophrenia. Though APDs are the first line drugs for these symptoms, other drugs than APDs to augment the effects of APDs are efficacious for the treatment of these symptoms. Such augmenting drugs include benzodiazepines, anticonvulsants, antidepressants, lithium, and electroconvulsive therapy. These augmentation strategies can boost the effects of APDs or decrease the requirements of APDs, and consequently decrease the chance of the occurrence of side effects of APDs. Augmenting strategies are revewed for each class of drugs or treatment modality.

• Clinical Psychopharmacology and Neuroscience
• /
• 제16권4호
• /
• pp.434-448
• /
• 2018

Objective: The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was first published in 2002 through an expert consensus of opinion, and updated in 2006, 2010, and 2014. This study constitutes the fourth revision of the KMAP-BP. Methods: A 50-item questionnaire was used to obtain the consensus of experts regarding pharmacological treatment strategies for various phases of adult bipolar disorder and six items for pediatric bipolar disorder. The review committee included 84 Korean psychiatrists and 43 child and adolescent psychiatry experts. Results: The preferred first-step strategies for acute mania were the combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP), MS monotherapy, and AAP monotherapy. A combination of a MS and an AAP, and AAP monotherapy were preferred for psychotic mania. The first-step strategies for mild to moderate bipolar depression were monotherapy with MS, AAP, or lamotrigine (LMT), and the combination of a MS and an AAP or LMT, or a combination of an AAP and LMT. The combination of two among a MS, AAP, and LMT were preferred for non-psychotic severe depression. A combination of a MS and an AAP or the combination of an AAP with an antidepressant or LMT were the first-line options for psychotic severe depression. Conclusion: The recommendations of the KMAP-BP 2018 have changed from the previous version by reflecting recent developments in pharmacotherapy for bipolar disorder. KMAP-BP 2018 provides clinicians with a wealth of information regarding appropriate strategies for treating patients with bipolar disorder.

• 생물정신의학
• /
• 제3권2호
• /
• pp.156-161
• /
• 1996

Many pregnant women have to receive psychotropic medication during pregnancy and lactation period, despite the proven and assumed risks to the fetus ar neonate. A brief summary of drug metabolism and pharmacodynamics is given. Principles and quidelines of using psychotropic agents during pregancy and lactation period are presented for psychotic disorders, bipolar affective disorders. depression and anxiety disorders, with due consideration for relative benefits and risks of choosing among psychotropic drugs and alternative treatments.

• 생물정신의학
• /
• 제12권1호
• /
• pp.20-31
• /
• 2005

Objectives:This study was designed to investigate the characteristics of personality changes and emotional distress using the Personality Assessment Inventory (PAI) in patients with traumatic brain injury(TBI), divided into mild (MTBI) and severe (STBI) groups according to the severity of injury. Methods:The subjects were consisted of 25 patients with MTBI, 25 patients with STBI, and 25 normal controls. They were interviewed with the PAI. The data were analyzed by ${\chi}^2$ test, analysis of variance and Tukey test. Results:The results were the followings. First, Negative Impression in validity scales was elevated above cutoff point(T score 70) in both MTBI and STBI groups. Second, the clinical scales of which scores elevated above the cutoff point were Somatic Complaints, Anxiety, Anxiety-Related Disorders, Depression, and Schizophrenia in the MTBI, and Somatic Complaints and Depression in the STBI. Third, the clinical subscales above the cutoff point were Conversion, Somatization, Health Concerns, Affective Anxiety, Physiological Anxiety, Traumatic Stress, Cognitive Depression, Affective Depression, Physiological Depression, Thought Disorder, and Affective Instability in the MTBI, and Health Concerns, Cognitive Depression, Affective Depression, and Physiological Depression in the STBI. Fourth, Suicide Ideation in treatment scales was the only scale above the cutoff point in the MTBI and the others of the treatment and interpersonal scales in the MTBI and all of these scales of the STBI were not elevated above the cutoff point. Fifth, the scales of which scores showed significant difference between the MTBI and the STBI were Somatic Complaints, Anxiety, Depression, and Suicide Ideation, the subscales were Conversion, Somatization, Health Concerns, Affective Anxiety, Physiological Anxiety, Physiological Depression, and Psychotic Experiences. Conclusion:These results suggest that the patients with MTBI had more somatic and anxiety symptoms, depressed mood, and suicidal ideation than the patients with STBI. These characteristics are generally consistent with clinical observation and findings from previous studies of the patients with TBI, and the PAI seems to be a beneficial adjunctive assessment tool for the evaluation of patients with traumatic brain injury.